Pharmaceutical Manufacturing-Plant Expansion-Pharma Company-Puerto Rican

Bristol-Myers expanding again in Puerto Rico

Bristol-Myers Squibb ($BMY) is again beefing up its manufacturing operations in Puerto Rico, this time to increase capacity for producing cardiovascular and Type 2 diabetes drugs.The Big Pharma company will lay out $165 million to expand its Humacao plant. Bristol-Myers will start with the addition of 82,000 square feet of new manufacturing space, and then follow up by renovating 83,150 square feet of existing space. The company will add 100 new jobs once the project finishes in 2016.Despite recent layoffs and regulatory scrutiny of manufacturing on the Caribbean island, Bristol-Myers likes it for manufacturing. "Puerto Rico's highly skilled workforce has contributed significantly to our existing operation and plays an important role in our company's future growth," said Ricardo Zayas, senior vice president of pharmaceutical manufacturing, in a statement.Reports of low-quality operations have painted a poor picture of some Puerto Rican drug manufacturing in recent years. GlaxoSmithKline ($GSK), Pfizer ($PFE), and Johnson & Johnson ($JNJ), in addition to BMS, have all had problems there. In 2007, BMS and GSK shuttered Puerto Rican plants, laying off hundreds in the process. Two years ago, Bristol-Myers had a run-in with the FDA over poor manufacturing practices at its Manati plant, which it resolved last summer.The Humacao expansion marks the second significant project for Bristol-Myers on the island. In 2009, it spent $200 million to expand its Manati facility.- here's the Bristol-Myers statementRelated Articles:
Bristol-Myers plots $165M plant expansion in Puerto Rico
Study: Quality problems more common at offshore plants
Lawmakers question FDA oversight of P.R. plants read more..

source:http://www.fiercepharmamanufacturing.com/

Pharmaceutical Manufacturing-Pharmaceutical Companies-President Barack Obama-Republican Candidates

Lobbying by Pharmaceutical Manufacturing | OpenSecrets

Pharmaceutical Manufacturing

Pharmaceutical companies, which develop both over-the-counter and prescription drugs, have been among the biggest political spenders for years. While the industry has traditionally supported Republican candidates, some key players have recently increased donations to Democratic candidates as the GOP’s power in Washington erodes. The pharmaceutical manufacturing industry will likely fair better this decade now that President Barack Obama’s initial plan to institute a public health insurance did not become a part of sweeping health care reform legislation signed into law in 2010. A government-run plan, because of its size, would have had considerable negotiating power to draw down drug prices. [Read more Background]

Top Contributors, 2011-2012

ContributorAmountPfizer Inc $702,391Amgen Inc $574,648AstraZeneca PLC $527,501Abbott Laboratories $406,773Merck & Co $363,041GlaxoSmithKline $325,741Eli Lilly & Co $264,762Novartis AG $205,209Bayer Corp $124,650Endo Pharmaceuticals $116,400Perrigo Co $111,475Mutual Pharmaceutical $105,000Allergan Inc $88,000Teva Pharmaceuticals USA $86,870Sanofi-Aventis $78,300Bristol-Myers Squibb $70,050Pharmaceutical Rsrch & Mfrs of America $65,450Nostrum Pharmaceuticals $62,300Cephalon Inc $61,250Takeda Pharmaceuticals North America $61,250...view more Contributors

Contribution Trends, 1990-2010

...view Totals

Lobbying Totals, 1998-2010

...view more Lobbying

Party Split, 1990-2010

Top Recipients, 2011-2012

CandidateOfficeAmountObama, Barack (D) $129,139Romney, Mitt (R) $89,300Upton, Fred (R-MI)House $77,575Brown, Scott P (R-MA)Senate $76,483Hatch, Orrin G (R-UT)Senate $69,400...view more Recipients

Average Contributions to Members of Congress, 1990-2010

...view more Money to Congress Data for the current election cycle were released by the Federal Election Commission on Monday, February 13, 2012 Feel free to distribute or cite this material, but please credit the Center for Responsive Politics. via opensecrets.org Posted via email from Jack's posterous read more..